Cabozantinib has a terminal half-life of roughly 120 hours (about 5 days) after a single dose. That means it takes approximately 25 days for the drug to be essentially eliminated from your body. During daily treatment, the effective half-life is shorter, around 55 hours, but the long terminal phase means trace amounts linger in your system for weeks after your last pill.
What the Half-Life Means in Practical Terms
A drug’s half-life is the time it takes for the amount in your blood to drop by half. Cabozantinib has two relevant numbers. The effective half-life of about 55 hours reflects how quickly blood levels fall during the period that matters most for its therapeutic effects. The terminal half-life of roughly 120 hours captures the slower, final phase of elimination, when small amounts are still clearing from deeper tissues.
As a rule of thumb, it takes about five half-lives for a drug to be considered fully cleared. Using the 120-hour terminal half-life, that works out to roughly 25 days. At that point, less than 3% of the last dose remains. If you’re taking cabozantinib daily and then stop, the higher drug levels that built up during treatment will take even longer to fall to negligible levels, because your body accumulated the drug over time.
How Your Body Breaks It Down
Cabozantinib is processed primarily by a liver enzyme called CYP3A4, which is responsible for breaking down a large share of all medications. This enzyme converts cabozantinib into inactive byproducts. A second enzyme, CYP2C9, plays a minor supporting role, but CYP3A4 does the heavy lifting, handling more than 80% of the drug’s metabolism.
After being broken down, the drug and its byproducts leave the body through two routes. In a study tracking a radiolabeled dose over 48 days, about 54% was recovered in feces and 27% in urine. The fact that more than half exits through the digestive tract rather than the kidneys is worth knowing: liver function has a bigger influence on how quickly you clear the drug than kidney function does.
Factors That Speed Up or Slow Down Clearance
Because CYP3A4 is the main enzyme responsible for clearing cabozantinib, anything that affects this enzyme changes how long the drug stays active. Strong CYP3A4 inhibitors, a category that includes certain antifungals, some antibiotics, and grapefruit juice, slow the enzyme down and cause cabozantinib to accumulate to higher levels. Strong CYP3A4 inducers, such as certain anti-seizure medications and the herbal supplement St. John’s wort, speed up the enzyme and can lower cabozantinib levels faster than expected.
Liver health matters too. Since the liver is the primary site of metabolism, reduced liver function can slow clearance and effectively extend the time the drug stays in your system. If you have moderate or severe liver impairment, your oncology team will typically adjust dosing to account for the slower breakdown.
The Surgery Washout Window
One of the most common reasons people ask about clearance time is surgery. Cabozantinib affects blood vessel formation and wound healing, so surgeons want it out of your system before operating. The standard conservative recommendation has been to stop the drug at least 21 days before a procedure, which aligns with roughly five terminal half-lives and near-complete washout.
More recent clinical data suggests a shorter window may be safe in certain situations. A phase 2 trial studying kidney cancer patients who underwent surgery after stopping cabozantinib found that a 14-day interval between the last dose and the operation was safe, with no surgical complications in the evaluated patients. As the lead investigators noted, the 21-day guideline was based on being conservative, and 14 days proved sufficient in their cohort. Your surgical and oncology teams will decide the right window based on the type of procedure and your individual circumstances.
Timeline After Stopping Treatment
Here’s a rough timeline of what to expect after your last dose of cabozantinib, based on the pharmacokinetic data:
- Days 1 to 3: Blood levels begin to drop noticeably. The effective half-life of 55 hours means levels fall by about half every two and a half days during this initial phase.
- Days 5 to 10: Most of the drug’s clinical effects are fading. You may start to notice side effects easing, though this varies from person to person.
- Days 14 to 21: The drug has cleared enough for surgical procedures to be considered safe. Residual amounts are still present but at very low levels.
- Days 25 to 30: The drug is essentially undetectable in most people. Virtually all of the final dose and its byproducts have been excreted.
Keep in mind that side effects don’t always track perfectly with blood levels. Some effects, particularly those related to blood pressure, fatigue, or changes in wound healing, can persist for a period after the drug itself has cleared, because the body needs time to reverse the biological changes the drug caused. If you’re stopping cabozantinib and want to know when a specific side effect should resolve, that conversation is best had with your treatment team, since it depends on which effect you’re dealing with and how long you were on the medication.